These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11195065)

  • 1. [Differential indications for induction therapy of non-small-cell lung tumors].
    Drings P; Manegold C
    Chirurg; 2000 Dec; 71(12):1466-73. PubMed ID: 11195065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?].
    Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A
    Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
    Van Meerbeeck JP; Van Schil PE; Senan S;
    J Thorac Oncol; 2007 Dec; 2(12):1138-9. PubMed ID: 18090593
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preoperative chemotherapy and chemoradiotherapy for non-small-cell bronchial cancers].
    Milleron B; Mornex F; Martin E; Epaud C; Massiani MA
    Cancer Radiother; 2002 Nov; 6 Suppl 1():105s-113s. PubMed ID: 12587388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.
    Tieu BH; Sanborn RE; Thomas CR
    Thorac Surg Clin; 2008 Nov; 18(4):403-15. PubMed ID: 19086609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.
    Deutsch M; Crawford J; Leopold K; Wolfe W; Foster W; Herndon J; Blackwell S; Yost R
    Cancer; 1994 Aug; 74(4):1243-52. PubMed ID: 8055445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant or neoadjuvant chemotherapy in minimal N2 stage IIIA nonsmall cell lung cancer.
    De Craene S; Surmont V; van Meerbeeck JP
    Curr Opin Oncol; 2010 Mar; 22(2):102-11. PubMed ID: 20180283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with resectable stage IIIA (N2) NSCLC.
    Azzoli CG
    J Surg Oncol; 2006 Dec; 94(7):551-2. PubMed ID: 17111389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Surgery and chemoradiation in stage IIIA non-small cell lung cancer].
    Hennequin C; Girard N; Mornex F
    Cancer Radiother; 2006 Nov; 10(6-7):477-83. PubMed ID: 17046307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chemotherapy in stages I to III non-small cell lung cancer.
    Strauss GM
    Chest; 1999 Dec; 116(6 Suppl):509S-516S. PubMed ID: 10619521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Byhardt RW; Sause WT; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
    Radiology; 2000 Jun; 215 Suppl():1331-45. PubMed ID: 11037550
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neoadjuvant chemotherapy and chemoradiotherapy in surgically treated non-small-cell stage III bronchial carcinoma].
    Hillejan L; Müller MR; Eberhardt W; Stüben G; Stamatis G
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():601-5. PubMed ID: 11824324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of multimodality therapy in locoregional non-small cell lung cancer.
    Martini N; Kris MG; Ginsberg RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):769-91. PubMed ID: 9309093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma.
    Clark JI; Albain KS
    Cancer Treat Res; 2001; 105():149-70. PubMed ID: 11224986
    [No Abstract]   [Full Text] [Related]  

  • 20. Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy.
    Mitsos S; Petko M; Patrini D; Hayward M; Scarci M; Lawrence D; Panagiotopoulos N
    Indian J Cancer; 2017; 54(1):73-81. PubMed ID: 29199668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.